Skip to main content
. 2012 Nov 7;2012:976740. doi: 10.1100/2012/976740

Figure 2.

Figure 2

Antiproliferative effects of coadministration of piroxicam (Pir) and deracoxib (Der) on canine mammary carcinoma cell line after 72 h incubation. Data are expressed as the percentage of inhibition compared with control in which cell survival was assumed as 100%. *P < 0.05 (n = 3).